This exceptional potency is complemented by remarkably sustained target suppression, maintaining >90% IDO1 degradation for over 48 h in human glioblastoma cell lines - a critical feature for overcoming the rapid protein turnover often observed in aggressive tumors. The gene discussed is IDO1; the disease is glioblastoma.